Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2026-02-28 @ 8:19 AM
Study NCT ID:
NCT02201420
Status:
COMPLETED
Last Update Posted:
2016-09-27
First Post:
2014-07-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT
Sponsor:
Navidea Biopharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09
Start Date Type:
None
Primary Completion Date:
2015-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-10
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-24
First Submit QC Date:
None
Study First Post Date:
2014-07-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-06-23
Results First Submit QC Date:
None
Results First Post Date:
2016-09-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-08-03
Last Update Post Date:
2016-09-27
Last Update Post Date Type:
ESTIMATED